Sentry Investment Management LLC Has $149,000 Holdings in Agilent Technologies, Inc. (NYSE:A)

Sentry Investment Management LLC decreased its holdings in Agilent Technologies, Inc. (NYSE:A) by 14.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,108 shares of the medical research company’s stock after selling 180 shares during the quarter. Sentry Investment Management LLC’s holdings in Agilent Technologies were worth $149,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Impax Asset Management Group plc raised its position in shares of Agilent Technologies by 6.1% in the fourth quarter. Impax Asset Management Group plc now owns 2,829,429 shares of the medical research company’s stock valued at $380,105,000 after buying an additional 161,813 shares in the last quarter. Rothschild Investment LLC increased its stake in Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after acquiring an additional 79 shares during the period. IFP Advisors Inc raised its holdings in Agilent Technologies by 17.7% in the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after acquiring an additional 69 shares in the last quarter. Y Intercept Hong Kong Ltd lifted its position in shares of Agilent Technologies by 50.1% during the 4th quarter. Y Intercept Hong Kong Ltd now owns 14,984 shares of the medical research company’s stock valued at $2,013,000 after acquiring an additional 4,998 shares during the period. Finally, Howard Capital Management Inc. grew its holdings in shares of Agilent Technologies by 6.1% during the 4th quarter. Howard Capital Management Inc. now owns 2,123 shares of the medical research company’s stock worth $285,000 after purchasing an additional 122 shares in the last quarter.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Wall Street Analyst Weigh In

A has been the subject of a number of analyst reports. Sanford C. Bernstein dropped their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Citigroup boosted their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. JPMorgan Chase & Co. cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Bank of America cut their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research note on Friday, December 13th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $144.38.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $134.51 on Thursday. The stock has a 50-day moving average price of $140.90 and a two-hundred day moving average price of $139.28. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35. The company has a market capitalization of $38.37 billion, a PE ratio of 30.43, a P/E/G ratio of 3.66 and a beta of 1.07. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. Agilent Technologies’s dividend payout ratio is 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.